医疗器械可沥滤物的安全性是医疗器械安全性的重要保证，也是近年来医疗器械审评过程中关注的重点。本文结合现有产品的审评，简述了高分子医疗器械可沥滤物安全性研究中残留量检测常见问题，并对其产生原因进行了解析，供相关机构及研发人员参考使用。
The safety of leachable substances of medical devices is an important guarantee for the safety of medical devices, and has also been the focus in the review process of medical devices in recent years. Combined with the review of existing products, the common problems of residual detection in safety study of leachable substances were briefly described, and the causes were analyzed, which could be used as a reference for relevant institutions and R & D personnels.
[1] GB/T 16886.17-2005医疗器械生物学评价第17部分:可沥滤物允许限量的建立[S]. 2005.
[2] 杨晓冬.高分子耗材可沥滤物的安全性评价[J].中国医疗器械杂志,2016,40(6):434-437.
[3] 党玺芸.基于体外循环管路新型增塑剂的研究[D].广东:华南理工大学,2017:45-46.
[4] 颜林,黄敏菊.两种浸提方法对环氧乙烷残留量测试结果的影响[J].医疗设备信息,2005,(6):70-74.
[5] ISO 10993.7-2008 Biological Evaluation of Medical Devices-Part 7:Ethylene Oxide Sterilization Residuals[S]. 2008.
[6] 王京辉,许玮仪,孙磊,等.中药中有害残留物痕量检测分析方法验证原则探讨[J].药物分析杂志,2012, 32(9):1704-1709.
[7] 冯晓明,奚廷斐.血袋中DEHP实时释放量的检测[J].中国医疗器械信息,2005,11(2):31-32.
[8] 刘成虎,吴平,骆红宇,等.一次性使用输血器生物学风险评定方法探讨[J].中国医疗器械信息,2016,22(3):47-51,80.
[9] 刘保峰,封琳敏,张明,等.甲苯二异氰酸酯毒性及其对职业接触人群健康影响研究进展[J].中国职业医学,2016,43(1):101-104.
[10] 季宇彬,于蕾,纪红蕊.甲苯二异氰酸酯对免疫系统的毒性及作用机制[J].哈尔滨工业大学学报,2005,37(3):362-367.
[11] Robyn L PrueittLorenz,R Rhomberg,管娜,等.甲苯二异氰酸酯(TDI)致癌性的综合评估[J].生态毒理学报,2016,11(4):26-60.
[12] Seel K,Walber U,Herbold B,et al. Chemical Behaviour of Seven Aromatic Disocyanates (Toluenediisocyanates and Diphenylmethane Disocyanates) Under in Vitro Conditions in Relationship to Their Results in the Salmonella/Microsome Test[J]. Mutation Research, 1999,438(2):109-123.
[13] 许明哲,黄宝斌,杨青云,等.分析方法确认内容介绍[J].药物分析杂志,2015,35(1):183-189.
[14] 许明哲,黄宝斌,杨青云,等.分析方法验证、转移和确认概念解析[J].药物分析杂志,2015,35(1):169-175.
